Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited.

× No keyword cloud information.

25 in total

1. GRK5 deficiency accelerates {beta}-amyloid accumulation in Tg2576 mice via impaired cholinergic activity.

Authors: Shaowu Cheng; Longxuan Li; Shuangteng He; Jun Liu; Yuning Sun; Minchao He; Kenneth Grasing; Richard T Premont; William Z Suo
Journal: J Biol Chem Date: 2010-11-01 Impact factor: 5.157

2. Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress.

Authors: Kaiyue Sun; Yuting Bai; Rong Zhao; Zijiao Guo; Xiang Su; Peiqi Li; Pengyu Yang
Journal: Metab Brain Dis Date: 2018-11-07 Impact factor: 3.584

3. Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells.

Authors: Jacques Barik; Federico Dajas-Bailador; Susan Wonnacott
Journal: Br J Pharmacol Date: 2005-08 Impact factor: 8.739

Review 4. Galantamine: a review of its use in Alzheimer's disease.

Authors: L J Scott; K L Goa
Journal: Drugs Date: 2000-11 Impact factor: 9.546

5. Synthesis of Novel 3-Aryl-N-Methyl-1,2,5,6-Tetrahydropyridine Derivatives by Suzuki coupling: As Acetyl Cholinesterase Inhibitors.

Authors: S B Benaka Prasad; Y C Sunil Kumar; C S Ananda Kumar; C T Sadashiva; K Vinaya; K S Rangappa
Journal: Open Med Chem J Date: 2007-09-05

Review 6. Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.

Authors: Abraham Fisher
Journal: Neurotherapeutics Date: 2008-07 Impact factor: 7.620

Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited.

1. GRK5 deficiency accelerates {beta}-amyloid accumulation in Tg2576 mice via impaired cholinergic activity.

2. Neuroprotective effects of matrine on scopolamine-induced amnesia via inhibition of AChE/BuChE and oxidative stress.

3. Cellular responses to nicotinic receptor activation are decreased after prolonged exposure to galantamine in human neuroblastoma cells.

Review 4. Galantamine: a review of its use in Alzheimer's disease.

5. Synthesis of Novel 3-Aryl-N-Methyl-1,2,5,6-Tetrahydropyridine Derivatives by Suzuki coupling: As Acetyl Cholinesterase Inhibitors.

Review 6. Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.

7. Activation of muscarinic receptors inhibits glutamate-induced GSK-3β overactivation in PC12 cells.

Review 8. Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor in Neurodegenerative Diseases.

Review 9. M1 muscarinic acetylcholine receptor in Alzheimer's disease.

10. Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.